1. Standardized CD3+ Cell Dose for Allogeneic Peripheral Blood Stem Cell Transplant (PBSCT): An Interim Analysis 
Muhammad Omer Jamil, MD, Ayman Saad, MD, Samantha Langford, Donna Salzman, MD, Racquel Innis-Shelton, MD, Luciano J. Costa, MD, PhD, Antonio di Stasi, MD, Shin Mineishi, MD, Lawrence Lamb, PhD 
Biology of Blood and Marrow Transplantation 
Volume 22, Issue 3, Pages S381-S382 (March 2016)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1 Immune reconstitution
Legend: A: CD3+ cell reconstitution overall for non-trial patients; B: CD8+ cell reconstitution for non-trial patients; C: CD4+ cell reconstitution for non-trial patients, D: NK cell reconstitution for non-trial patients, E: CD3+ cell reconstitution overall fortrial patients; F: CD8+ cell reconstitution for trial patients; G:CD4+ cell reconstitution fortrial patients; H: NK cell reconstitution fortrial patients
Biology of Blood and Marrow Transplantation  , S381-S382DOI: ( /j.bbmt )
Copyright © Terms and Conditions